Kyrgyzstan and Kazakhstan discuss joint procurement of medicines for 2027
A working meeting was held at the state enterprise Kyrgyzfarmatsiya with a delegation from Kazakhstan’s single pharmaceutical distributor, SK-Pharmacy LLP.
According to the state enterprise, the visit by the Kazakh delegation to Kyrgyzstan was organized to exchange experience, strengthen bilateral partnership and develop integration in centralized medicine procurement. The sides presented their current activities and discussed practical mechanisms for cooperation in detail.
Key areas of discussion
- Joint procurement mechanisms. The parties discussed consolidated approaches and procedures for conducting joint procurement of medicines and medical products for 2027. They considered consolidating demand, optimizing procurement procedures and reducing the cost of pharmaceutical products through increased volumes of direct supplies and more efficient budget spending.
- Addressing pharmaceutical market challenges. The sides discussed current issues related to logistics, pricing and ensuring uninterrupted supplies amid modern challenges.
- Prospects and joint plans. The parties agreed on a long-term action plan and outlined further steps to strengthen intergovernmental cooperation.
«Following the negotiations, the parties recorded the main agreements reached and outlined a further framework for joint work to provide the population with high-quality and affordable pharmaceutical products. Cooperation with the Kazakh distributor opens up new opportunities to develop a more efficient medicine supply system across the region,» Kyrgyzfarmatsiya said.
The state enterprise Kyrgyzpharmatsiya was established in 2023 to ensure transparent centralized procurement and uninterrupted supplies of medicines and medical products to state hospitals across the country. However, patients have repeatedly reported problems with supplies.
According to Order No. 1 of the Ministry of Health dated January 1, 2026, the state enterprise centrally procures 191 types of medicines. Medical institutions may purchase independently any medicines not included in this list.